E-Greetings from the Allergy Advocacy Association

March 2021

Greetings. March brings us daylight savings time, St. Patrick’s Day and the NCAA Basketball tournament. But before Spring arrives the Allergy Advocacy is already busy raising awareness of the dangers of life-threatening allergies. In this issue we’ll provide a preview of our lobbying efforts for “Teacher Training,” proposed legislation for anaphylaxis emergency training in NYS public schools. This issue also contains three articles on interesting and important research. From looking at ways to desensitize peanut allergic toddlers, to exploring the fill rate of prescriptions for epinephrine auto-injectors to discovering the role a natural protein plays in allergies and autoimmune conditions, we offer our readers the very latest information.

When allergic reactions happen, learn how to take action! Our Epi Near You NY anaphylaxis emergency training program is now VIRTUAL! Our cost-free seminars provide:

  • Free state approved training presentation
  • New York State recognized certification
  • Assistance for public entities to obtain a non-patient specific prescription for emergency epinephrine.

Find upcoming training webinar dates here.

Enjoy "March Madness" while it lasts! Be safe and healthy! Best wishes!

The Case for "Teacher Training" in NYS Public Schools

One in 13 children have food allergies; that equals two kids at risk for anaphylaxis in every classroom across America. The data from the Center for Disease and Control shows that twenty-five to 30% of anaphylactic reactions occur at school without a prior diagnosis. That is why the Allergy Advocacy Association, building on the success of our past legislative efforts, is working to find new ways to promote “Teacher Training” for the administration of life-saving epinephrine in NYS Public Schools.

The Case for "Teacher Training" in NYS Public Schools

New York State Capitol with Flags and Reflecting Pool, Albany NY

By Jon Terry
18 March 2021

Greetings. Concerning life-threatening allergies and anaphylaxis, just how safe are kids in New York State public schools? What laws are currently in place to protect kids from anaphylaxis emergencies? Are there loopholes, gaps or errors in childcare at our schools that need to be corrected? While discussing these questions in this article the Allergy Advocacy Association provides context.

Continue Reading

Strong Results for SLIT Therapy Seen in Peanut-Allergic Toddlers

Imagine you're the parent of a toddler with a life threatening peanut allergy. Imagine your concern, anxiousness and daily vigilance as you try to keep your child safe. Now imagine there was a therapy that helped desensitize your peanut-allergic little one so that an encounter with a peanut wasn’t fatal. We might not have to imagine much longer. Sublingual immunotherapy (SLIT) has been referred to as “super promising” by Dr. Edwin Kim, an assistant professor of allergy and immunology at the University of North Carolina at Chapel Hill and the study’s lead author.

Strong Results for SLIT Therapy Seen in Peanut-Allergic Toddlers

Mother and toddler

By: Jenifer Goodwin
February 28, 2021

In a small study, sublingual immunotherapy (SLIT) was effective in desensitizing peanut-allergic toddlers, allowing 74 percent to consume 4,443 milligrams of peanut (about 15 peanuts) without reacting, new research finds.

“What we are seeing is super-promising,” says lead study author Dr. Edwin Kim, an assistant professor of allergy and immunology at the University of North Carolina at Chapel Hill. “We observed significant desensitization in toddlers with peanut allergy,” he told Allergic Living.

Continue Reading

Just Half of Epinephrine Auto-Injector Prescriptions are Filled After Pediatric Emergency Discharge

We know that a life-threatening allergic reaction can be fatal. We also know that when anaphylaxis strikes an epinephrine auto-injector can save a person’s life. So why after a pediatric emergency discharge were only half of the prescriptions for an epinephrine auto-injector filled by patients? A new study examines this important issue.

Just Half of Epinephrine Auto-Injector Prescriptions are Filled After Pediatric Emergency Discharge

Image of Emergency sign plus image of Injector packet

By Dave Bloom
2021/03/09

A child develops anaphylaxis and is rushed to the emergency room. At the time the child is stabilized and released, a physician writes a prescription for an epinephrine auto-injector (EAI) which a staffer eventually hands to the accompanying adult, sending them on their way. But how many of those prescriptions are actually filled and by whom?

A recent study published in Allergy and Asthma Proceedings aimed at measuring those fill rates while looking for racial and socioeconomic disparities.

Continue Reading

Researchers Find a Natural Protein That Halts Allergies

What if the “cure” for some autoimmune allergies like asthma and life threatening anaphylaxis could be found in our own bodies? That is what researchers from the Australian National University (ANU) may have discovered in the protein called neuritin. The role of this natural protein plays in the brain and nervous system has been known for years but five years ago researchers began to look at the role it may play in the immune system. The results are promising and researchers hope that they may be the basis for new treatments.

Researchers Find a Natural Protein That Halts Allergies

Dr Paula Gonzalez Figueroa MD
Dr Paula Gonzalez Figueroa, MD

Dr Paula Gonzalez Figueroa
News Wire ~ 3rd Party Press Release — Australian National University
03-12-2021

Researchers have discovered a function in the immune system that could hold the key to treating allergic conditions like asthma and stop life-threatening anaphylaxis.

Experts from The Australian National University (ANU) have unearthed a natural way the body prevents autoimmune disease and allergies. The process is driven by a protein in the body called neuritin.

“We found this absolutely fascinating mechanism of our own bodies that stops the production of rogue antibodies that can cause either autoimmunity or allergies,” senior author, ANU Professor Carola Vinuesa, said.

Continue Reading